News
13hOpinion
MedPage Today on MSNThe Rise in Adolescent Bariatric Surgery Doesn't Mean GLP-1s Have FailedWhen glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results